LLMpediaThe first transparent, open encyclopedia generated by LLMs

Cas12

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: CRISPR gene editing Hop 4
Expansion Funnel Raw 105 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted105
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Cas12
NameCas12

Cas12. Cas12 is a class of Type V CRISPR-Cas system effector protein, a RNA-guided endonuclease that has become a cornerstone of modern genome editing and molecular diagnostics. It was first identified through bioinformatics analysis of microbial genomes and later characterized for its unique enzymatic properties. Unlike the well-known Cas9, Cas12 exhibits distinct structural features and a biochemical mechanism that involves cleavage of both target and non-target DNA strands, leading to its widespread adoption in biotechnology.

Overview and Discovery

The discovery of Cas12 emerged from systematic investigations into the diversity of CRISPR-Cas systems across prokaryotes, spearheaded by researchers like Jennifer Doudna, Feng Zhang, and Virginijus Šikšnys. Initial genomic sequencing projects, such as those analyzing metagenomic data from environmental samples, revealed novel cas gene loci distinct from the Type II system harboring Cas9. Key work from the Broad Institute and the University of California, Berkeley demonstrated that these systems, classified as Type V, contained a single, large effector protein. The foundational characterization of its DNA cleavage activity was published in major journals like Science and Nature, establishing it as a powerful tool for genetic engineering.

Structure and Mechanism

The structure of Cas12, solved using techniques like X-ray crystallography and cryo-electron microscopy, reveals a bilobed architecture comprising a REC lobe and a NUC lobe. It complexes with a single CRISPR RNA (crRNA) to form a ribonucleoprotein that surveys cellular DNA for protospacer adjacent motif (PAM) sequences, typically rich in thymine nucleotides. Upon PAM recognition and DNA duplex unwinding, the RuvC domain of Cas12 initiates a double-stranded break via a nickase-like activity that first cleaves the non-target strand. This triggers conformational changes leading to trans-cleavage or collateral cleavage of nearby single-stranded DNA molecules, a property absent in Cas9.

Subtypes and Classification

Cas12 encompasses multiple subtypes, classified primarily within the Type V CRISPR-Cas system by the CRISPR-Cas classification scheme. Notable variants include Cas12a (formerly Cpf1), originally discovered in Francisella novicida and Acidaminococcus species, and Cas12b, identified in Alicyclobacillus acidoterrestris. Other members like Cas12c, Cas12d, and Cas12e exhibit variations in PAM specificity, protein size, and thermostability. The International Society for CRISPR Research and databases like CRISPRdb help catalog these subtypes, which are derived from diverse bacterial phyla and archaeal lineages.

Applications in Biotechnology

The unique trans-cleavage activity of Cas12 has been harnessed for sensitive nucleic acid detection, most notably in platforms like SHERLOCK developed at the Broad Institute and DETECTR created by Mammoth Biosciences. These systems enable rapid diagnosis of pathogens such as Zika virus, Dengue virus, and SARS-CoV-2. In therapeutic development, Cas12 is used for gene knockout in cell lines, animal models like Mus musculus, and plant genome editing in Oryza sativa and Nicotiana benthamiana. Companies like Caribou Biosciences and Editas Medicine are exploring its use in ex vivo therapies for sickle cell disease and beta-thalassemia.

Comparison with Other CRISPR Systems

Compared to Cas9 from Streptococcus pyogenes, Cas12 requires only a single RNA guide and generates staggered ends with DNA overhangs, unlike the blunt ends produced by Cas9. It also lacks a tracrRNA component, simplifying guide RNA design. While Cas13 targets RNA molecules, Cas12 exclusively cleaves DNA substrates. The collateral damage effect of Cas12 is more pronounced than in Type I systems like Cascade complex, but its smaller size facilitates delivery via adeno-associated virus vectors. Ongoing research at institutions like the Max Planck Institute and the Wellcome Sanger Institute continues to elucidate the evolutionary relationships and functional trade-offs among these nuclease families.

Category:CRISPR Category:Proteins Category:Molecular biology